Krzysztof Brzozka
Chief Tech/Sci/R&D Officer at RYVU THERAPEUTICS S.A.
Net worth: 3 M $ as of 2024-04-29
Krzysztof Brzozka active positions
| Companies | Position | Start | End |
|---|---|---|---|
| RYVU THERAPEUTICS S.A. | Chief Tech/Sci/R&D Officer | 2014-07-16 | - |
| Corporate Officer/Principal | 2006-12-31 | 2014-07-16 | |
Ardigen SA
 Ardigen SA Packaged SoftwareTechnology Services Ardigen SA is a precision medicine company based in Kraków, Poland. The Polish company specializes in using advanced artificial intelligence methods to accelerate therapy development by decoding microbiome, designing immunity, and providing digital drug discovery services. Ardigen's team has deep expertise in bioinformatics, machine learning, and software engineering, and their in-house datasets and platforms for immunology, biomarker, and microbiome research can empower effective pharmaceuticals development. The private company was founded by Pawel Przewiezlikowski, and the CEO is Janusz Homa. | Director/Board Member | - | - |
Career history of Krzysztof Brzozka
Training of Krzysztof Brzozka
| Uniwersytet Jagiellonski | Graduate Degree |
| Ludwig-Maximilians-Universität München | Doctorate Degree |
| Cracow University of Economics | Masters Business Admin |
| Stockholm Business School | Masters Business Admin |
Statistics
International
| Poland | 5 |
| Germany | 2 |
| Sweden | 2 |
Operational
| Masters Business Admin | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Consumer Services | 5 |
| Health Technology | 2 |
| Technology Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| RYVU THERAPEUTICS S.A. | Health Technology |
| Private companies | 1 |
|---|---|
Ardigen SA
Ardigen SA Packaged SoftwareTechnology Services Ardigen SA is a precision medicine company based in Kraków, Poland. The Polish company specializes in using advanced artificial intelligence methods to accelerate therapy development by decoding microbiome, designing immunity, and providing digital drug discovery services. Ardigen's team has deep expertise in bioinformatics, machine learning, and software engineering, and their in-house datasets and platforms for immunology, biomarker, and microbiome research can empower effective pharmaceuticals development. The private company was founded by Pawel Przewiezlikowski, and the CEO is Janusz Homa. | Technology Services |
- Stock Market
- Insiders
- Krzysztof Brzozka
- Experience
